0
In This Issue
The Initial Field Trials of DSM-5: New Blooms and Old Thorns
Robert Freedman, M.D.; David A. Lewis, M.D.; Robert Michels, M.D.; Daniel S. Pine, M.D.; Susan K. Schultz, M.D.; Carol A. Tamminga, M.D.; Glen O. Gabbard, M.D.; Susan Shur-Fen Gau, M.D., Ph.D.; Daniel C. Javitt, M.D., Ph.D.; Maria A. Oquendo, M.D., Ph.D.; Patrick E. Shrout, Ph.D.; Eduard Vieta, M.D., Ph.D.; Joel Yager, M.D.
A Simple Question Answered: Adding Moderate-Dosage Lithium Does Not Help Patients With Bipolar Disorder
Boadie W. Dunlop, M.D., M.S.; Jeffrey J. Rakofsky, M.D.; Mark Hyman Rapaport, M.D.
Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
Helen M. Pettinati, Ph.D.; Charles P. O’Brien, M.D., Ph.D.; William D. Dundon, Ph.D.
Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis
Alan C. Swann, M.D.; Beny Lafer, M.D.; Giulio Perugi, M.D.; Mark A. Frye, M.D.; Michael Bauer, M.D.; Won-Myong Bahk, M.D.; Jan Scott, M.D.; Kyooseob Ha, M.D.; Trisha Suppes, M.D., Ph.D.
DSM-5 Field Trials in the United States and Canada, Part I: Study Design, Sampling Strategy, Implementation, and Analytic Approaches
Diana E. Clarke, Ph.D., M.Sc.; William E. Narrow, M.D., M.P.H.; Darrel A. Regier, M.D., M.P.H.; S. Janet Kuramoto, Ph.D., M.H.S.; David J. Kupfer, M.D.; Emily A. Kuhl, Ph.D.; Lisa Greiner, M.S.S.A.; Helena C. Kraemer, Ph.D.
DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses
Darrel A. Regier, M.D., M.P.H.; William E. Narrow, M.D., M.P.H.; Diana E. Clarke, Ph.D., M.Sc.; Helena C. Kraemer, Ph.D.; S. Janet Kuramoto, Ph.D., M.H.S.; Emily A. Kuhl, Ph.D.; David J. Kupfer, M.D.
DSM-5 Field Trials in the United States and Canada, Part III: Development and Reliability Testing of a Cross-Cutting Symptom Assessment for DSM-5
William E. Narrow, M.D., M.P.H.; Diana E. Clarke, Ph.D., M.Sc.; S. Janet Kuramoto, Ph.D., M.H.S.; Helena C. Kraemer, Ph.D.; David J. Kupfer, M.D.; Lisa Greiner, M.S.S.A.; Darrel A. Regier, M.D., M.P.H.
Effect of a Paraprofessional Home-Visiting Intervention on American Indian Teen Mothers’ and Infants’ Behavioral Risks: A Randomized Controlled Trial
Allison Barlow, M.A., M.P.H.; Britta Mullany, Ph.D., M.H.S.; Nicole Neault, M.P.H.; Scott Compton, Ph.D.; Alice Carter, Ph.D.; Ranelda Hastings, B.S.; Trudy Billy, B.S.; Valerie Coho-Mescal; Sherilynn Lorenzo; John T. Walkup, M.D.
CME   Randomized Controlled Trial of Contingency Management for Stimulant Use in Community Mental Health Patients With Serious Mental Illness
Michael G. McDonell, Ph.D.; Debra Srebnik, Ph.D.; Frank Angelo, M.A.; Sterling McPherson, Ph.D.; Jessica M. Lowe, B.A.; Andrea Sugar, B.A.; Robert A. Short, Ph.D.; John M. Roll, Ph.D.; Richard K. Ries, M.D.
Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium
Andrew A. Nierenberg, M.D.; Edward S. Friedman, M.D.; Charles L. Bowden, M.D.; Louisa G. Sylvia, Ph.D.; Michael E. Thase, M.D.; Terence Ketter, M.D.; Michael J. Ostacher, M.D., M.P.H.; Andrew C. Leon, Ph.D.; Noreen Reilly-Harrington, Ph.D.; Dan V. Iosifescu, M.D.; Michael Pencina, Ph.D.; Joanne B. Severe, M.S.; Joseph R. Calabrese, M.D.
Deciphering the Neural Signature of Conversion Blindness
Benjamin Becker, Ph.D.; Dirk Scheele, M.Sc.; Rainald Moessner, M.D.; Wolfgang Maier, M.D.; René Hurlemann, M.D., Ph.D.
Altered Functional and Structural Connectivity in a Schizophrenia Patient With Complete Agenesis of the Corpus Callosum
Swati Rane, Ph.D.; Samet Kose, M.D., Ph.D.; John C. Gore, Ph.D.; Stephan Heckers, M.D.
Drawings During Neuropsychiatric Recovery From Anti-NMDA Receptor Encephalitis
Maite M. Esseveld, M.D.; Emma H.C.W. van de Riet, M.D.; Leen Cuypers, M.D.; Jan N.M. Schieveld, M.D., Ph.D.